Real-time PCR assays for strain-specific quantification of probiotic strains in human faecal samples

International Dairy Journal

Volumn 27, Issue 1-2, 2012, Pages 58-64

  Karjalainen, Heli ^a   Ahlroos, Terhi ^a   Myllyluoma, Eveliina ^a   Tynkkynen, Soile ^a  

^a VALIO LTD   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL STRAINS; BIFIDOBACTERIUM; DETECTION LIMITS; FAECAL SAMPLES; HUMAN FAECAL; LACTOBACILLUS RHAMNOSUS; LINEAR RANGE; ORDERS OF MAGNITUDE; PROBIOTIC STRAIN; PROPIONIBACTERIUM FREUDENREICHII SSP. SHERMANII; QUANTITATIVE REAL TIME PCR; RANDOMLY AMPLIFIED POLYMORPHIC DNA; REAL-TIME PCR; REAL-TIME PCR ASSAY;

ASSAYS; BACILLI; DNA SEQUENCES; GENES;

POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BREVE; LACTOBACILLUS RHAMNOSUS; PROPIONIBACTERIUM FREUDENREICHII;

EID: 84866266132     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2012.07.006     Document Type: Article

References (39)

1. Ahlroos T., Tynkkynen S. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. Journal of Applied Microbiology 2009, 106:506-514.
2. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 1997, 25:3389-3402.
3. Brandt K., Alatossava T. Specific identification of certain probiotic Lactobacillus rhamnosus strains with PCR primers based on phage-related sequences. International Journal of Food Microbiology 2003, 84:189-196.
4. Brigidi P., Vitali B., Swennen E., Altomare L., Rossi M., Matteuzzi D. Specific detection of Bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction. Systematic and Applied Microbiology 2000, 23:391-399.
5. Doron S., Snydman D.R., Gorbach S.L. Lactobacillus GG: bacteriology and clinical applications. Gastroenterology Clinics of North America 2005, 34:483-498.
6. El-Nezami H., Mykkänen H., Kankaanpää P., Suomalainen T., Salminen S., Ahokas J. Ability of a mixture of Lactobacillus and Propionibacterium to influence the faecal aflatoxin content in healthy Egyptian volunteers: a pilot clinical study. Bioscience and Microflora 2000, 19:41-45.
7. T, a hardy actinobacterium with food and probiotic applications. PLoS ONE 2010, 5:e11748. 10.1371/journal.pone.0011748.
8. FAO/WHO Guidelines for the evaluation of probiotics in food 2002, Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food, World Health Organization, London, Ontario, Canada, Accessed 14.04.09. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
9. Fujimoto J., Matsuki T., Sasamoto M., Tomii Y., Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. International Journal of Food Microbiology 2008, 126:210-215.
10. Haarman M., Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2006, 72:2359-2365.
11. Hatakka K., Ahola A.J., Yli-Knuuttila H., Richardson M., Poussa T., Meurman J.H., et al. Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial. Journal of Dental Research 2007, 86:125-130.
12. Hervé C., Fondrevez M., Chéron A., Barloy-Hubler F., Jan G. Transcarboxylase mRNA: a marker which evidences P. freudenreichii survival and metabolic activity during its transit in the human gut. International Journal of Food Microbiology 2007, 113:303-314.
13. Kajander K., Hatakka K., Poussa T., Färkkilä M., Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Alimentary Pharmacology and Therapeutics 2005, 22:387-394.
14. Kajander K., Krogius-Kurikka L., Rinttilä T., Karjalainen H., Palva A., Korpela R. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2007, 26:463-473.
15. Kankainen M., Paulin L., Tynkkynen S., von Ossowski I., Reunanen J., Partanen P., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:17193-17198.
16. Kekkonen R.A., Lummela N., Karjalainen H., Latvala S., Tynkkynen S., Järvenpää S., et al. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World Journal of Gastroenterology 2008, 14:2029-2036.
17. Konstantinov S.R., Smidt H., de Vos W.M. Representational difference analysis and real-time PCR for strain-specific quantification of Lactobacillus sobrius sp. nov. Applied and Environmental Microbiology 2005, 71:7578-7581.
18. Lahtinen S.J., Gueimonde M., Ouwehand A.C., Reinikainen J.P., Salminen S. Probiotic bacteria may become dormant during storage. Applied and Environmental Microbiology 2005, 71:1662-1663.
19. Lahtinen S.J., Gueimonde M., Ouwehand A.C., Reinikainen J.P., Salminen S. Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product. Food Microbiology 2006, 23:571-577.
20. Lucchini F., Kmet V., Cesena C., Coppi L., Bottazzi V., Morelli L. Specific detection of a probiotic Lactobacillus strain in faecal samples by using multiplex PCR. FEMS Microbiology Letters 1998, 158:273-278.
21. Maruo T., Sakamoto M., Toda T., Benno Y. Monitoring the cell number of Lactococcus lactis subsp. cremoris FC in human feces by real-time PCR with strain-specific primers designed using the RAPD technique. International Journal of Food Microbiology 2006, 110:69-76.
22. Masco L., Vanhoutte T., Temmerman R., Swings J., Huys G. Evaluation of real-time PCR targeting the 16S rRNA and recA genes for the enumeration of bifidobacteria in probiotic products. International Journal of Food Microbiology 2007, 113:351-357.
23. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and Environmental Microbiology 2004, 70:167-173.
24. Moore D., Dowhan D. Purification and concentration of DNA from aqueous solution. Current protocols in molecular biology 2002, 2.1.1-2.1.10. John Wiley & Sons, Inc, New York, NY, USA. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith (Eds.).
25. Mottet C., Michetti P. Probiotics: wanted dead or alive. Digestive and Liver Disease 2005, 37:3-6.
26. Myllyluoma E., Ahlroos T., Veijola L., Rautelin H., Tynkkynen S., Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. International Journal of Antimicrobial Agents 2007, 29:66-72.
27. Myllyluoma E., Kajander K., Mikkola H., Kyrönpalo S., Rasmussen M., Kankuri E., et al. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Digestive and Liver Disease 2007, 39:516-523.
28. Myllyluoma E., Veijola L., Ahlroos T., Tynkkynen S., Kankuri E., Vapaatalo H., et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Alimentary Pharmacology and Therapeutics 2005, 21:1263-1272.
29. Requena T., Burton J., Matsuki T., Munro K., Simon M.A., Tanaka R., et al. Identification, detection and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Applied and Environmental Microbiology 2002, 68:2420-2427.
30. Rinttilä T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology 2004, 97:1166-1177.
31. Rochet V., Rigottier-Gois L., Sutren M., Krementscki M.-N., Andrieux C., Furet J.-P., et al. Effects of orally administered Lactobacillus casei DN-114001 on the composition or activities of the dominant faecal microbiota in healthy humans. British Journal of Nutrition 2006, 95:421-429.
32. Sanders M.E. Probiotics. Food Technology 1999, 53:67-77.
33. Satokari R.M., Vaughan E.E., Smidt H., Saarela M., Mättö J., de Vos W.M. Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Systematic and Applied Microbiology 2003, 26:572-584.
34. Saxelin M., Tynkkynen S., Mattila-Sandholm T., de Vos W.M. Probiotic and other functional microbes: from markets to mechanisms. Current Opinion in Biotechnology 2005, 16:204-211.
35. Saxelin M., Tynkkynen S., Salusjärvi T., Kajander K., Myllyluoma E., Sandholm-Mattila T., et al. Developing a multispecies probiotic combination. International Journal of Probiotics and Prebiotics 2010, 5:169-182.
36. Suomalainen T.H., Mäyrä-Mäkinen A.M. Propionic acid bacteria as protective cultures in fermented milks and breads. Lait 1999, 79:165-174.
37. Tilsala-Timisjärvi A., Alatossava T. Strain-specific identification of probiotic Lactobacillus rhamnosus with randomly amplified polymorphic DNA-derived PCR primers. Applied and Environmental Microbiology 1998, 64:4816-4819.
38. Valeur N., Engel P., Carbajal N., Connolly E., Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Applied and Environmental Microbiology 2004, 70:1176-1181.
39. Ventura M., Reniero R., Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolated by a combined multiplex-PCR approach. Applied and Environmental Microbiology 2001, 67:2760-2765.